John C Lang

10PUBLICATIONS
8CO-AUTHORS
Econometric and statistical methodsFoetal development and medicineSocio-economic developmentInfant and child healthEpidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Sep 26, 2026
Reply to Hodges et al. Comment on "Kura et al. Cost-Effectiveness Analysis of Clesrovimab for Respiratory Syncytial Virus in Infants in the United States. Vaccines 2026, 14, 411".

|Sep 26, 2026
Estimating and Projecting Efficacy of Monoclonal Antibodies Against Respiratory Syncytial Virus Beyond Clinical Trial Periods.

|Jun 29, 2026
Estimating the Long-Term Clinical and Economic Impact of Universal Varicella Vaccination in Portugal Using a Dynamic Transmission Model.

|May 26, 2026
Cost-Effectiveness Analysis of Clesrovimab for Respiratory Syncytial Virus in Infants in the United States.

|Jan 09, 2026
Modeling the clinical and economic impact of universal varicella vaccination in Belgium with dynamic population.

John C Lang, Robert B Nachbar, Ilaria Xausa

|Jun 27, 2025
Predicting the Epidemiological Effects in the United Kingdom of Moving from PCV13 to PCV15 in the Routine Pediatric 1 + 1 Vaccination Schedule.

Rachel J Oidtman, Natalie Banniettis, Jessica Weaver

Pageof 2

Frequent Collaborators

2 joint publications

Elamin H Elbasha

1 joint publications

Ian R Matthews

1 joint publications

Tufail M Malik

1 joint publications

Oluwaseun Sharomi